Understanding Flu Vaccine Immunity in COVID-19 Patients
This study aims to understand how well the flu vaccine works in people who have had COVID-19. Researchers will give all participants a single flu shot and then measure their immune response (how their body fights off infection) one week and one month later. They are looking for adults and children aged 9 to 64 who have had COVID-19, including those with conditions like obesity, diabetes, chronic fatigue, or long-term COVID-19 symptoms. People who have not had COVID-19 can also join as a comparison group. The study is currently unclear on its recruitment status, but plans to enroll 230 participants.
- Study design
- This is an observational study planning to enroll 230 participants. All participants will receive a single flu shot.
- What's involved
- All participants will receive a single flu shot. Their immunity to the flu vaccine will be tested at one week and one month after the shot.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one month after receiving the flu vaccine to test their immunity.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Understanding Immunity to the Flu Vaccine in COVID-19 Patients
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Sayantani Sindher, MD · PRINCIPAL_INVESTIGATOR · Stanford University
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Testing immunity to the flu vaccine over time1 week
- Testing immunity to the flu vaccine over time1 month